Olfr444, a prominent member of the olfactory receptor family, functions as a key player in initiating neuronal responses essential for smell perception. These receptors, characterized by a 7-transmembrane domain structure, are integral components of the G-protein-coupled receptor (GPCR) family. Olfr444 is responsible for recognizing and transducing signals from odorant molecules, contributing to the intricate process of olfactory perception. Inhibition of Olfr444 involves a comprehensive approach with a diverse set of chemicals targeting specific signaling pathways and cellular processes associated with the receptor. The direct inhibitor, Tetrodotoxin, blocks voltage-gated sodium channels, impairing action potentials in olfactory neurons and limiting the propagation of signals initiated by Olfr444 activation. Indirect inhibitors, such as Wortmannin and H89, disrupt the PI3K-Akt and cAMP signaling pathways, respectively, impacting downstream cascades crucial for Olfr444 function. Additionally, modulators of calcium dynamics (Ionomycin and EGTA) and inhibitors of vesicle trafficking (Brefeldin A) indirectly affect Olfr444 by disrupting processes essential for signal transduction and neuronal response to odorants.
Furthermore, chemical modulators like Thioridazine and Fumonisin B1 influence dopamine receptors and sphingolipid metabolism, respectively, providing an indirect means of inhibiting Olfr444 function. The altered signaling cascades and cellular processes collectively contribute to impaired olfactory receptor function, limiting the receptor's ability to mediate the transduction of odorant signals and initiate a proper neuronal response to smells. This multifaceted approach to Olfr444 inhibition highlights the intricate nature of olfactory signal processing and offers valuable insights for further research into the regulatory mechanisms governing olfactory perception.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $138.00 $380.00 | 101 | |
Indirect inhibitor targeting the DNA repair pathway. By inducing DNA damage, Cisplatin activates p53, leading to cell cycle arrest. Olfr444 inhibition occurs through the downstream impact on the cellular processes associated with DNA repair, disrupting the receptor's function in signal transduction. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Inhibitor of PI3K, influencing the PI3K-Akt signaling pathway. Wortmannin disrupts the downstream cascade associated with Olfr444, indirectly inhibiting the olfactory receptor by affecting processes crucial for signal transduction and neuronal response to odorants. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Calcium ionophore impacting intracellular calcium concentrations. This indirect inhibitor disrupts calcium-dependent processes involved in the recognition and transduction of odorant signals by Olfr444, impairing the olfactory receptor's ability to initiate a neuronal response to smells. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Inhibitor of vesicle trafficking and protein transport. This indirect inhibition interferes with the proper localization of olfactory receptor proteins, disrupting their availability on the cell membrane. Olfr444 function in signal recognition and transduction is impaired due to altered receptor localization. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Inhibitor of PI3K, disrupting the PI3K-Akt signaling pathway. LY294002 interferes with the downstream cascade associated with Olfr444, indirectly inhibiting the olfactory receptor by affecting processes crucial for signal transduction and neuronal response to odorants. | ||||||
EGTA | 67-42-5 | sc-3593 sc-3593A sc-3593B sc-3593C sc-3593D | 1 g 10 g 100 g 250 g 1 kg | $21.00 $65.00 $120.00 $251.00 $815.00 | 23 | |
Chelator of extracellular calcium ions. This indirect inhibitor disrupts the availability of calcium ions crucial for olfactory signal transduction by Olfr444. The altered calcium dynamics impair the receptor's ability to mediate the transduction of odorant signals and initiate a proper neuronal response to smells. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
Inhibitor of MEK1/2, disrupting the MAPK signaling pathway. U0126 interferes with the downstream cascade associated with Olfr444 activation, indirectly inhibiting the olfactory receptor by affecting processes crucial for signal transduction and neuronal response to odorants. | ||||||
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $182.00 | 25 | |
Inhibitor of CaMKII, disrupting calcium-dependent signaling. KN-93 impacts the downstream processes initiated by Olfr444 activation, indirectly inhibiting the olfactory receptor by interfering with calcium-mediated transduction of odorant signals. The altered calcium signaling limits the neuronal response triggered by Olfr444. | ||||||
Thioridazine | 50-52-2 | sc-473180 | 50 mg | $500.00 | ||
Modulator of dopamine receptors. This indirect inhibitor influences downstream pathways associated with Olfr444, affecting the receptor's function in signal transduction and neuronal response to odorants. The altered dopaminergic signaling limits the olfactory receptor's ability to mediate the transduction of odorant signals. | ||||||
Fumonisin B1 | 116355-83-0 | sc-201395 sc-201395A | 1 mg 5 mg | $200.00 $680.00 | 18 | |
Inhibitor of ceramide synthase, impacting sphingolipid metabolism. Fumonisin B1 indirectly inhibits Olfr444 by disrupting cellular processes crucial for signal transduction and neuronal response to odorants. The altered sphingolipid metabolism limits the olfactory receptor's ability to mediate the transduction of odorant signals. | ||||||